Encompass Health's CFO Trimmed His Stake as Shares Jumped After Earnings. Here's What to Know

Encompass Health's CFO Douglas Coltharp sold 18,869 shares worth $2.4 million on August 10, reducing his direct stake by 27% but maintaining a total beneficial ownership of 241,000 shares valued at $30.4 million. The sale occurred the same day as the CEO's larger stake reduction, following strong Q2 earnings that included 10% revenue growth, raised full-year guidance, and increased dividend/buyback authorization.